FDA Clears Siemens AIDAN Artificial Intelligence for Biograph PET/CT IAM Network

April 22, 2020 -- Siemens Healthineers has received clearance from the Food and Drug Administration (FDA) for its AIDAN artificial intelligence technologies on the Biograph family of positron emission tomography/computed tomography (PET/CT) systems, which includes the Biograph Horizon, Biograph mCT, and Biograph Vision. AIDAN is built on a foundation of patient-focused bed design and proprietary AI deep-learning technology to enable four new features – FlowMotion AI, OncoFreeze AI, PET FAST Workflow AI, and Multiparametric PET Suite AI. Siemens Healthineers PET/CT systems with AIDAN offer enhanced protection against cyber threats via syngo Security – a security package for general regulatory security rules that enables compliance with the Health Insurance and Accountability Act (HIPAA). FlowMotion AI Because each patient's body habitus and presentation of disease is different, tailoring PET/CT protocols to produce the highest-quality diagnostic imaging information possible for each patient can be difficult and time-consuming. The standard one-size-fits-all protocol lacks personalization and is often of suboptimal quality.